Red cells from the original JAL+ proband are also DAK+ and STEM+

Vox Sanguinis

Volumn 101, Issue 1, 2011, Pages 61-64

  Hue Roye, K ^a   Reid, M E ^a   Westhoff, C M ^a,b   Lomas Francis, C ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b Molecular Blood Group and Platelet Testing Laboratory   (United States)

Author keywords

Blood groups; Low prevalence antigens; Rh blood groups

Indexed keywords

DNA; REAGENT; RHESUS ANTIBODY; RHESUS ANTIGEN; RHESUS DAK ANTIGEN; RHESUS JAL ANTIGEN; RHESUS STEM ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; DNA DETERMINATION; ERYTHROCYTE; GENETIC CODE; GENETIC VARIABILITY; HEMAGGLUTINATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTIGENIC VARIATION; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTES; HEMAGGLUTINATION; HEMAGGLUTINATION TESTS; HUMANS; ISOANTIGENS; PHENOTYPE; RH-HR BLOOD-GROUP SYSTEM;

EID: 79958841836     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01465.x     Document Type: Article

References (16)

1. Lomas C, Poole J, Salaru N, et al.: A low-incidence red cell antigen JAL associated with two unusual Rh gene complexes. Vox Sang 1990; 59:39-43
2. Poole J, Hustinx H, Gerber H, et al.: The red cell antigen JAL in the Swiss population: family studies showing that JAL is an Rh antigen (RH48). Vox Sang 1990; 59:44-47
3. Hustinx H, Poole J, Bugert P, et al.: Molecular basis of the Rh antigen RH48 (JAL). Vox Sang 2009; 96:234-239
4. Lomas-Francis C, Reid ME, Westhoff C, et al.: JAL (RH48) blood group antigen: serological observations. Transfusion 2009; 49:719-724
5. Westhoff C, Vege S, Wylie D, et al.: The JAL Antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp. Transfusion 2009; 49:725-732
6. Reid ME, Storry JR, Sausais L, et al.: DAK, a new low-incidence antigen in the Rh blood group system. Transfusion 2003; 43:1394-1397
7. Bizot M, Lomas C, Rubio F, et al.: An antiserum identifying a red cell determinant expressed by Rh:33 and by some "new" depressed Rh phenotypes. Transfusion 1988; 28:342-345
8. B+, STEM+ phenotype (abstract). Transfusion 2010; 50(Suppl):48A
9. *ce alleles: clinical implications. Transfusion 2010; 50:1303-1311
10. Noizat-Pirenne F, Lee K, Le Pennec P-Y, et al.: Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002; 100:4223-4231
11. Schmerer WM, Hummel S, Herrmann B: Optimized DNA extraction to improve reproducibility of short tandem repeat genotyping with highly degraded DNA as target. Electrophoresis 1999; 20:1712-1716
12. Souldsbury CD, Iossa G, Edwards KJ, et al.: Allelic dropout from a high-quality DNA source. Conserv Genet 2007; 8:733-738
13. Johnson PC, Haydon DT: Maximum-likelihood estimation of allelic dropout and false allele error rates from microsatellite genotypes in the absence of reference data. Genetics 2007; 175:827-842
14. *nt818C>T change encode the low prevalence Rh antigen STEM (abstract). Blood 2009; 114(Suppl):1226-1227
15. Avent ND, Poole J, Singleton B, et al.: Studies of two partial Ds: DMH and DOL. Transfus Med 1999; 9(Suppl):33; Abstract
16. Daniels G: Human Blood Groups, 2nd edn. Oxford, Blackwell Science Ltd., 2002; 501 pp